Back to BlackRock, Inc. BlackRock, Inc.

ALLOALLO
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ALLOGENE THERAPEUTICS INC

BlackRock, Inc. holds 30.1M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $62.7M as of 2026-Q2. The position was increased (+57.9% shares). ALLO represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$62.7M

Current Shares

30.1M

Total Value Change

+$24.2M

Total Shares Change

+12.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
30.1M
+57.9%
$62.7M0.0%$2.08
42
2026-Q1
Increased
19.1M
+8.0%
$46.6M0.0%$2.53
32
2025-Q4
Increased
17.7M
+0.9%
$24.2M0.0%$1.31
29
2025-Q3
Decreased
17.5M
-2.1%
$21.7M0.0%$1.27
0
2025-Q2
Decreased
17.9M
-0.2%
$20.2M0.0%$1.18
0
2025-Q1
Decreased
17.9M
-0.7%
$26.2M0.0%$1.55
0
2024-Q4
New
18.1M
-
$38.5M0.0%$2.10
40

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used